Bruker Corporation BRKR | NASDAQ
|2026-09-23
|F&G 64
|RSI 57.3
Company Overview:
10 Year BRKR Performance Metrics:
BRKR Dividend Charts
Unlock All Reports & Research Dividend Stocks like a BOSS!
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
BRKR Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
BRKR Dividends Info:
BRKR Dividend History: Dates, Payments & Yield list
Below is a schedule of all BRKR dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield
| Ex-Date | Payment Date | Amount | Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 09/21/2026 | 10/07/2026 | $0.050 | 0.32% | 0.34% | $59.67 |
| 06/22/2026 | 07/07/2026 | $0.050 | 0.35% | 0.34% | $58.25 |
| 03/23/2026 | 04/07/2026 | $0.050 | 0.57% | 0.55% | $36.67 |
| 12/08/2025 | 01/02/2026 | $0.050 | 0.43% | 0.42% | $48.11 |
| 09/23/2025 | 10/03/2025 | $0.050 | 0.6% | 0.54% | $36.98 |
| 06/16/2025 | 06/27/2025 | $0.050 | 0.51% | 0.48% | $41.80 |
| 03/17/2025 | 03/28/2025 | $0.050 | 0.43% | 0.48% | $42.08 |
| 12/02/2024 | 12/16/2024 | $0.050 | 0.34% | 0.35% | $57.18 |
| 08/30/2024 | 09/16/2024 | $0.050 | 0.3% | 0.31% | $65.28 |
| 05/31/2024 | 06/17/2024 | $0.050 | 0.31% | 0.31% | $64.85 |
| 06/03/2024 | 06/17/2024 | $0.050 | 0.31% | 0.31% | $64.85 |
| 02/29/2024 | 03/15/2024 | $0.050 | 0.23% | 0.22% | $92.10 |
| 11/30/2023 | 12/15/2023 | $0.050 | 0.31% | 0.27% | $73.36 |
| 08/31/2023 | 09/15/2023 | $0.050 | 0.3% | 0.3% | $66.43 |
| 05/31/2023 | 06/16/2023 | $0.050 | 0.29% | 0.26% | $75.48 |
| 02/28/2023 | 03/17/2023 | $0.050 | 0.29% | 0.28% | $72.18 |
| 11/30/2022 | 12/16/2022 | $0.050 | 0.3% | 0.31% | $64.41 |
| 08/31/2022 | 09/16/2022 | $0.050 | 0.36% | 0.38% | $52.88 |
| 05/31/2022 | 06/17/2022 | $0.050 | 0.32% | 0.34% | $59.28 |
| 02/28/2022 | 03/18/2022 | $0.050 | 0.28% | 0.29% | $68.64 |
| 11/30/2021 | 12/17/2021 | $0.040 | 0.2% | 0.2% | $78.55 |
| 08/31/2021 | 09/17/2021 | $0.040 | 0.18% | 0.19% | $83.35 |
| 05/28/2021 | 06/18/2021 | $0.040 | 0.23% | 0.22% | $72.29 |
| 03/04/2021 | 03/19/2021 | $0.040 | 0.27% | 0.26% | $60.69 |
| 11/30/2020 | 12/18/2020 | $0.040 | 0.32% | 0.29% | $55.48 |
| 08/31/2020 | 09/18/2020 | $0.040 | 0.38% | 0.41% | $38.63 |
| 05/29/2020 | 06/19/2020 | $0.040 | 0.37% | 0.39% | $41.09 |
| 03/06/2020 | 03/20/2020 | $0.040 | 0.36% | 0.47% | $34.37 |
| 11/29/2019 | 12/20/2019 | $0.040 | 0.31% | 0.31% | $51.61 |
| 08/30/2019 | 09/20/2019 | $0.040 | 0.37% | 0.37% | $43.54 |
| 05/31/2019 | 06/21/2019 | $0.040 | 0.38% | 0.33% | $48.76 |
| 03/04/2019 | 03/22/2019 | $0.040 | 0.41% | 0.42% | $38.10 |
| 11/30/2018 | 12/21/2018 | $0.040 | 0.48% | 0.6% | $26.50 |
| 08/31/2018 | 09/21/2018 | $0.040 | 0.45% | 0.49% | $32.87 |
| 06/01/2018 | 06/22/2018 | $0.040 | 0.52% | 0.53% | $30.01 |
| 03/05/2018 | 03/23/2018 | $0.040 | 0.54% | 0.55% | $29.12 |
| 12/01/2017 | 12/22/2017 | $0.040 | 0.46% | 0.47% | $34.08 |
| 08/31/2017 | 09/22/2017 | $0.040 | 0.55% | 0.54% | $29.36 |
| 06/01/2017 | 06/23/2017 | $0.040 | 0.58% | 0.53% | $29.98 |
| 03/06/2017 | 03/24/2017 | $0.040 | 0.67% | 0.69% | $23.19 |
| 12/01/2016 | 12/23/2016 | $0.040 | 0.71% | 0.74% | $21.53 |
| 09/01/2016 | 09/23/2016 | $0.040 | 0.71% | 0.72% | $22.37 |
| 06/02/2016 | 06/24/2016 | $0.040 | 0.6% | 0.7% | $22.90 |
| 03/02/2016 | 03/24/2016 | $0.040 | 0.57% | 0.58% | $27.43 |
Projected Future Returns & Dividends for BRKR
Based on past 10-year performance, here are BRKR growth metrics:
Share price CAGR of +10.96%
Dividend CAGR of +2.26%
Using BRKR CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| BRKR (DRIP) | BRKR - No DRIP | |
|---|---|---|
| Current Price | $63.23 | $63.23 |
| Start Shares | 158.15 | 158.15 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 161.75 | 158.15 |
| Dividends Payment | $0.06 | $0.06 |
| Annual Dividends | $40 | $40 |
| Yield on cost | 0.40% | 0.40% |
| Share Price | $178.96 | $178.96 |
| Total Dividends | $355 | $350 |
| Final Value | $28,948 | $28,654 |
NOTE: Above numbers are our estimate based on BRKR's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Company Info
Bruker Corporation (BRKR) had its IPO on 2000-08-04, and is traded on NASDAQ stock exchange.
Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
BRKR website: https://www.bruker.com
Get Full Access to All Reports with DRIPCalc PRO
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
DCF Model — BRKR
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
| Year | FCF | Implied price |
|---|
